Compound Detail
CHEMBL187709
TRIPARANOL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL187709 |
| Name | TRIPARANOL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | SYHDSBBKRLVLFF-UHFFFAOYSA-N |
6
Targets
16
Activities
2
Assay Types
0
PK Parameters
17
Publications
2
Known Names
1
Mechanisms
Molecular Properties
438.0
MW (Da)
5.85
ALogP
3
HBA
1
HBD
32.7
PSA (Ų)
0.43
QED
1
Ro5 Violations
10
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Withdrawn |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Delta(24)-sterol reductase inhibitor | INHIBITOR | Delta(24)-sterol reductase | ✓ | ✓ |
Drug Warnings
Withdrawn
dermatological toxicity
Cataracts, Alopecia, lchthyosis
Withdrawn
dermatological toxicity
Cataracts, Alopecia, lchthyosis
Withdrawn
occular toxicity
Cataracts, Alopecia, lchthyosis
Activity Summary
IC50 13 meas. best 6.53
Ki 3 meas. best 8.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| C-8 sterol isomerase ERG2 CHEMBL3224 | Ki | 8.7 | 8.7 | 2.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | Ki | 8.1 | 8.1 | 8.0 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase CHEMBL4931 | Ki | 7.96 | 7.96 | 11.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.53 | 5.4033 | 298.7 | 9 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 5.33 | 5.2233 | 4680.0 | 3 |
| HL-60 CHEMBL383 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 28964935 | 10.1016/j.ejmech.2017.08.011 | HL-60 | 6 |
| 17428028 | 10.1021/ci6004542 | Phospholipidosis | 3 |
| - | 10.1101/2020.03.25.008482 | ADMET | 2 |
| - | 10.1101/2020.03.25.008482 | Vero C1008 | 2 |
| - | 10.1101/2020.03.25.008482 | SARS-CoV-2 | 2 |
| 26789657 | 10.1021/acs.jmedchem.5b01696 | Delta(24)-sterol reductase | 1 |
| - | 10.1101/2020.03.20.999730 | ADMET | 1 |
| - | 10.1101/2020.03.20.999730 | Vero | 1 |
| - | 10.1101/2020.03.20.999730 | SARS-CoV-2 | 1 |
| 28964935 | 10.1016/j.ejmech.2017.08.011 | Delta(24)-sterol reductase | 1 |
| 16033255 | 10.1021/jm049073+ | 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 1 |
| 26789657 | 10.1021/acs.jmedchem.5b01696 | 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 1 |
| - | 10.6019/CHEMBL3301361 | No relevant target | 1 |
| 20020916 | 10.1080/15376510701857262 | Phospholipidosis | 1 |
| 20799726 | 10.1021/mp100103e | Phospholipidosis | 1 |
| 16033255 | 10.1021/jm049073+ | C-8 sterol isomerase ERG2 | 1 |
| 16033255 | 10.1021/jm049073+ | Sigma non-opioid intracellular receptor 1 | 1 |
Data from ChEMBL 36 via Core Engine